Abstract:The small intestine is the primary site of drug absorption following oral administration, making paramount the proper monitoring of the absorption process. In vitro tools to predict intestinal absorption are particularly important in preclinical drug development since they are less laborious and cost-intensive and raise less ethical considerations compared to in vivo studies. The Caco-2 model is considered the gold standard of in vitro intestinal models regarding the prediction of absorption of orally delivered compounds. However, this model presents several drawbacks, such as the expression of tighter tight junctions, not being suitable to perform permeability of paracellular compounds. Besides, cells are representative of only one intestinal cell type, without considering the role of non-absorptive cells on the absorption pathway of drugs. In the present study, we developed a new three-dimensional (3D) intestinal model that aims to bridge the gap between in vitro tools and animal studies. Our 3D model comprises a collagen layer with human intestinal fibroblasts (HIFs) embedded, mimicking the intestinal lamina propria and providing 3D support for the epithelium, composed of Caco-2 cells and mucus-producing HT29-MTX cells, creating a model that can better resemble, both in terms of composition and regarding the outcomes of drug permeability when testing paracellular compounds, the human small intestine. The optimization of the collagen layer with HIFs was performed, testing different collagen concentrations and HIF seeding densities in order to avoid collagen contraction before day 14, maintaining HIF metabolically active inside the collagen disks during time in culture. HIF morphology and extracellular matrix (ECM) deposition were assessed, confirming that fibroblasts presented a normal and healthy elongated shape and secreted fibronectin and laminin, remodeling the collagen matrix. Regarding the epithelial layer, transepithelial electrical resistance (TEER) values decreased when cells were in the 3D configuration, comparing with the 2D analogs (Caco-2 and coculture of Caco-2+HT29-MTX models), becoming more similar with in vivo values. The permeability assay with fluorescein isothiocyanate (FITC)-Dextran 4 kDa showed that absorption in the 3D models is significantly higher than that in the 2D models, confirming the importance of using a more biorelevant model when testing the paracellular permeability of compounds.

An advanced in silico model of the oral mucosa reveals the impact of extracellular spaces on chemical permeation

An innovative in silico model of the oral mucosa reveals the impact of extracellular spaces on chemical permeation through epithelium

Mechanistic Analysis of Chemical Permeation Enhancers for Oral Drug Delivery

Finite element model of the non-keratinized buccal tissue under the impact of negative pressure

Predicting nanocarrier permeation across the human intestine : Model matters

Development of a novel in vitro 3D intestinal model for permeability evaluations

Development of an Improved 3D in vitro Intestinal Model to Perform Permeability Studies of Paracellular Compounds

Predicting Nanocarrier Permeation Across the Human Intestine In Vitro: Model Matters

Impact of gut permeability on estimation of oral bioavailability for chemicals in commerce and the environment

Types and Evaluation of in Vitro Penetration Models for Buccal Mucosal Delivery

Optimization of micro-fabricated porous membranes for intestinal epithelial cell culture and in vitro modeling of the human intestinal barrier

Model-Informed Drug Development: In Silico Assessment of Drug Bioperformance following Oral and Percutaneous Administration

Modeling Transdermal Permeation. Part I. Predicting Skin Permeability of Both Hydrophobic and Hydrophilic Solutes

In Silico Prediction of Percutaneous Absorption and Disposition Kinetics of Chemicals

Validation of a Caco-2 microfluidic Chip model for predicting intestinal absorption of BCS Class I-IV drugs

Modeling mucus physiology and pathophysiology in human organs-on-chips

Highly predictive and interpretable models for PAMPA permeability

Advances in models for predicting drug intestinal permeability

Development of an Oral Epithelial Ex Vivo Organ Culture Model for Biocompatibility and Permeability Assessment of Biomaterials

A Synthetic Model of the Mucosa for Oral Penetration Studies

A Method for Evaluating Drug Penetration and Absorption Through Isolated Buccal Mucosa with Highly Accuracy and Reproducibility